Cargando…
External Validation of the Prognostic Value of an Immune-Associated Gene Panel for Clear Cell Renal Cell Carcinomas
Clear cell renal cell carcinomas (ccRCCs) are highly immune infiltrates, and many of them respond to immunotherapy with checkpoint inhibitors including anti-PD-L1 or anti-PD1 agents. However, the effect of immune genes on clinical outcomes in ccRCCs has not been fully studied. Here, we show in this...
Autores principales: | Xie, Zhiwen, Wu, Lei, Hua, Shan, Zhang, Yongqing, Shi, Fei, Chen, Min, Zhao, Sheng, Liu, Zhihong, Liu, Meng, Jiang, Juntao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733896/ https://www.ncbi.nlm.nih.gov/pubmed/35004689 http://dx.doi.org/10.3389/fcell.2021.794840 |
Ejemplares similares
-
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022) -
Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021) -
DNA Methylation-Based Panel Predicts Survival of Patients With Clear Cell Renal Cell Carcinoma and Its Correlations With Genomic Metrics and Tumor Immune Cell Infiltration
por: Liu, Xiao-Ping, et al.
Publicado: (2020) -
Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma
por: Zhou, Haiting, et al.
Publicado: (2023) -
Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)